RD 03 SPR 115828
Laufzeit: 01.01.2017 - 31.12.2018
imported
Kurzfassung
A study to assess the safety and efficacy of nemolizumab (CD14152) in subjects with prurigo nodularis
Laufzeit: 01.01.2017 - 31.12.2018
A study to assess the safety and efficacy of nemolizumab (CD14152) in subjects with prurigo nodularis
